±±Ê¦´óϸ°ûÉúÎïѧ£º V7=SV:+1or
Ò»¡¢ Ãû´Ê½âÊÍ£º ]Ql 0v"` F
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© F=@i6ERi
2£® PCR£¨96£© (N~$x
3£® ·ºËØ£¨ubquitin£©£¨96£© H*e'Cs/
4£® °é·Ö×Ó£¨chapron£©£¨96£© 96|[}:+$&:
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© >`V}U*}*H
6£® DG£IP3£¨96£© |qjZ38;6
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© aSaAC7sFk
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© B0mLI%B
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© gp< =Gmd
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© /Ic[N&
11£® Transformation£¨92£© R"6;NPeo
12£® TransfectionתȾ£¨92£© )Id2GV~2B
13£® Transcytosis×ªÒÆ×÷Óã¨92£© P{oAObP%
14£® Transductionתµ¼£¨92£© Sgj/s~j~1
15£® Transdetermination£¨92£© }Zl"9A#K
16£® Transdifferentiation£¨92£© #1Z7R/
17£® Transgenic animalת»ùÒò¶¯Î92£© i+(GNcg2
18£® Rb£1£¨92£© E8[XG2ye
19£® P53£¨92¡¢91£© ,ECAan/@
20£® C£jun£¨92£© !L\'Mk/=A
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© VWvoQf^+
22£® °ûÄÚÌ壨99£© }C~]=Z
23£® Cyclin dependent kinase inhibitor(CDKI)(99) E/O5e(h
24£® G£protein£¨91£© TgaYt\"i[
25£® Restriction point£¨91£© \|+/0USn
26£® Antipost£¨91£© uW[3G
27£® Capping£¨91£© |cTpw1%I~
28£® TATAbox£¨91£© !t-K<'
29£® cDNA library£¨90£© :EB,{|m
30£® Aritotic apparatus£¨90£© b(T@~P/
31£® ¿çĤÐźŠtransmembrane signal£¨90£© HF4Lqh'oco
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© B7 c[4
33£® Nuclear lamina£¨90£© 8eX8IR!K9
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© _t.FL@3e
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© n6cq\@~A
36£® ϸ°û·Ö»¯£¨00£© BJIQ
zn3
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© "?H+
u/
8$
38£® ¿Ë¡£¨00£© aL)Hv k:
39£® »ùÒò×飨00£© /co%:}ln
40£® Caspase£¨00£© Q7k.+2
41£® ת¼Òò×Ó£¨00£© ak2dn]]D
42£® ÅßÌ¥¸Éϸ°û£¨01£© ay[ZsQC
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© !3x*k;0
44£® DNAоƬ£¨01£© C1ZyB"{
¶þ¡¢ ÎÊ´ðÌ⣺ %BICt @E
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© A\g%
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© 7vNtv9
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© qb$_xIQpDL
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© MC
d F!{
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© Lupy:4AD
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© %^U"Spv;
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© ,4yG(O$)
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© /.)2d8,
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© Z fqQ{_
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© X\'E4
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© wO!%
q[
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© Kt6C43]7
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© t.L4%1OF
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© >\&= [C
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© 9nO(xJ"e4
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© )1K! [W}t
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© h-,?a_
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© q
/:T1a7!
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© |yU3Kt
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© A$N+9n\
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© q>P[n z%
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© /t$*W\PL@
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© v10mDr
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© %B0w~[!4}
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© 4 *H(sq
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© G~`'E&/
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© cNx
\&vpd
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© i'Wcf1I-=
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© K_Z+]]$#
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© 7t`E@dm
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© (y
3~[
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© F68},N>vr@
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© -*r
[
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© Y'2-yB
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©